Visionary Wealth Advisors Takes Position in CVS Health Corporation $CVS

Visionary Wealth Advisors bought a new stake in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 11,986 shares of the pharmacy operator’s stock, valued at approximately $1,240,000.

A number of other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in CVS Health in the second quarter valued at approximately $12,747,462,000. Norges Bank acquired a new position in shares of CVS Health during the fourth quarter worth approximately $1,666,265,000. Wellington Management Group LLP lifted its holdings in shares of CVS Health by 193.2% in the 4th quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock worth $1,473,270,000 after purchasing an additional 12,233,675 shares in the last quarter. Pzena Investment Management LLC acquired a new stake in CVS Health in the 2nd quarter valued at $1,217,558,000. Finally, Bank of New York Mellon Corp acquired a new stake in CVS Health in the 2nd quarter valued at $932,454,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS opened at $94.06 on Tuesday. The firm has a market cap of $120.31 billion, a P/E ratio of 24.88, a PEG ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm has a 50-day moving average of $101.88 and a 200 day moving average of $89.08.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the previous year, the company earned $1.81 earnings per share. The company’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

Analysts Set New Price Targets

CVS has been the topic of several research reports. Wells Fargo & Company upped their price objective on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. DA Davidson boosted their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Bank of America upped their target price on shares of CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.